Van Berkom & Associates Inc. has initiated a significant new position in Option Care Health (OPCH), acquiring 1,587,636 shares valued at approximately $51.54 million, according to a May 7, 2026, SEC filing. This investment represents 1.41% of the firm’s total reportable assets under management as of March 31, 2026. Despite the recent purchase, Option Care’s shares have faced considerable pressure, down 37.5% year-over-year, following disappointing earnings that revealed only a 1.3% revenue increase and a 6.3% drop in adjusted EBITDA.
This move by Van Berkom comes amid a challenging backdrop for Option Care, which has seen its stock plummet after management cut full-year revenue guidance. However, the company’s position as the largest independent provider of home infusion services suggests potential long-term growth in a sector with increasing demand. The recent expansion of its credit facility and stock repurchase program may also signal management’s confidence in future recovery.
For investors, this transaction highlights a potential opportunity in a distressed asset. If Option Care can navigate its current challenges and return to a growth trajectory, the recent selloff may prove to be an overreaction, presenting a compelling entry point for those willing to take a long-term view.
Source: fool.com